InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
InMed Pharmaceuticals Inc. - Common Shares (INM)
Company Research
Source: Seeking Alpha
Eric Adams - President, CEO & Director Conference Call Participants Sean Gillis Presentation Operator Hello, and welcome to InMed Pharmaceuticals, Inc. 2025 Annual General Meeting of Shareholders. I will now turn the call over to Eric Adams, CEO. Please go ahead. Eric Adams President, CEO & Director Thank you. Ladies and gentlemen, the annual general and special meeting of InMed Pharmaceuticals will now come to order. My name is Eric A. Adams. I'm the President, CEO and a Director of InMed Pharmaceuticals. I will act as Chair of this meeting. I ask that Sean Gillis of Norton Rose Fulbright Canada LLP and Legal Counsel to the company, act as Secretary of this meeting. And I appoint Jessica De La Torre of Odyssey Trust Company as scrutineer of this meeting. The Secretary has tabled for inspection by any shareholder or proxyholder a sworn declaration that the notice calling this meeting and the accompanying materials, including the information circular were mailed to a
Show less
Read more
Impact Snapshot
Event Time:
INM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INM alerts
High impacting InMed Pharmaceuticals Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
INM
News
- Life Sciences Virtual Investor Forum Agenda Announced for December 11thGlobeNewswire
- InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 [Yahoo! Finance]Yahoo! Finance
- InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M [Seeking Alpha]Seeking Alpha
INM
Sec Filings
- 12/19/25 - Form 4
- 12/19/25 - Form 4
- 12/19/25 - Form 4
- INM's page on the SEC website